COMMUNIQUÉS West-GlobeNewswire

Cell Therapy Industry Pioneer, Gwendolyn Binder, Ph.D., to Join Cabaletta Bio Leadership Team
12/12/2018
Dr. Binder is an expert in T cell product development, translational research and GMP manufacturing Joins Cabaletta Bio as Executive Vice President, Science & Technology on February 1, 2019 RADNOR, Pa., Dec. 12, [...]
Adaptimmune Announces that Gwen Binder will leave in January 2019
12/12/2018
PHILADELPHIA and OXFORD, United Kingdom, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Adaptimmune (Nasdaq: ADAP), a leader in T-cell therapy to treat cancer, today announced that Gwen Binder, PhD, Chief Technology Officer, will be [...]
Grown Rogue Moves into California’s $5 Billion Cannabis Market -- CFN Media
12/12/2018
SEATTLE, Dec. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Terra Tech Subsidiary Edible Garden to Participate in The New York Produce Show and Conference December 12th
12/12/2018
IRVINE, Calif., Dec. 12, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. ( TRTC ) ("Terra Tech") or (the "Company"), a vertically integrated cannabis-focused agriculture company, today announced that its wholly-owned [...]
Hemispherx Biopharma Issues Letter to Stockholders
12/12/2018
Business Update and Apple iOS Stocks Advisory OCALA, Fla., Dec. 12, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) announces that Thomas K. Equels, President and Chief Executive Officer, has [...]
Preclinical Data on Vaccinex, Inc. Anti-SEMA4D Monoclonal Antibody in Combination with Checkpoint Inhibitors Published in Cancer Immunology Research
12/12/2018
ROCHESTER, N.Y., Dec. 12, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and [...]
Zosano Receives Conditional FDA Acceptance of Proposed Brand Name Qtrypta™ for M207
12/12/2018
FREMONT, Calif., Dec. 12, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug [...]
Kane Biotech Launches Four New bluestem™ Products
12/12/2018
WINNIPEG, Manitoba, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”), today announced it will be launching 4 new products under its bluestem™ brand in [...]
XBiotech’s Results from Phase 2 Atopic Dermatitis Study Suggest New Drug to Treat Skin Disease
12/12/2018
Bermekimab Therapy Rapidly and Significantly Reduces Disease AUSTIN, Texas, Dec. 12, 2018 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today that its open label, proof of concept, multicenter study using [...]
PSIQ Executes Agreement with Saboneto Soap Company, Amid Farm Bill, to Exclusively Produce PSIQ’s Hemp Infused Organic Soap with Dead Sea Salts
12/12/2018
SUNRISE, Fla., Dec. 12, 2018 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announces it has executed an agreement with Saboneto Soaps (“Saboneto”) for Saboneto to exclusively produce PSIQ subsidiary Elite [...]
Precipio Reports Strong Mid-Quarter Growth
12/12/2018
Key Metrics Indicate Continued Growth QoQ for Fourth Quarter 2018 NEW HAVEN, Conn., Dec. 12, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced today that based on metrics [...]
Nuvectra Receives Full-Body MR-Conditional CE Mark Approval for Algovita®
12/12/2018
PLANO, Texas, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has received full-body MR-conditional approval for the Company’s [...]
HealthEC Announces Beaumont ACO as New Client for Population Health Management Solution
12/12/2018
HealthEC, which also serves as PHM provider for Beaumont Health, to provide comprehensive support for ACO’s value-based care initiatives EDISON, N.J., Dec. 12, 2018 (GLOBE NEWSWIRE) -- HealthEC , a KLAS-recognized end- [...]
Helsinn Group Announces new Permanent J Code for AKYNZEO® (fosnetupitant and palonosetron) for injection in the US
12/12/2018
Helsinn Group Announces new Permanent J Code for AKYNZEO ® (fosnetupitant and palonosetron) for injection in the US Akynzeo ® for injection received a permanent J code, J1454 , in the US, by the Centers for Medicare and [...]
CTD Holdings to Present at WORLD Symposium on Lysosomal Storage Diseases
12/12/2018
ALACHUA, Fla., Dec. 12, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, [...]
IntelGenx Partners with Gensco® Pharma to Market RIZAPORT® in the United States
12/12/2018
SAINT LAURENT, Quebec, Dec. 12, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced the execution of a definitive licensing, [...]
Progressive Care Inc. Announces Record-Breaking November 2018
12/12/2018
MIAMI, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and a record-breaking [...]
AzurRx BioPharma to Acquire Payment Rights to Lead Drug Candidate MS1819-SD from Protea Biosciences Group
12/12/2018
Eliminates milestone and royalty payments to Protea Biosciences Group NEW YORK, Dec. 12, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing in the [...]
Sera Prognostics Receives New York State Approval for PreTRM® Testing
12/12/2018
SALT LAKE CITY, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s health company, announced today that the New York State Department of Health has issued a clinical laboratory permit for Sera to [...]

Pages